News | September 17, 2021
Skyhawk Therapeutics Completes New Investment Round
Read More
News | September 17, 2021
DICE Therapeutics Announces Pricing of Upsized Initial Public Offering
Read More
News | September 17, 2021
ImCheck Presents Preliminary Patient Response Data from the Phase I/IIa EVICTION Trial with ICT01 at ESMO Congress 2021
Read More
Press Release | August 18, 2021
Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases
Read More
News | July 13, 2021
ImCheck Publishes Seminal Paper in Cell Reports Elucidating How Butyrophilins Activate Vγ9Vδ2 T cell Function Against Tumor Cells
Read More
News | June 1, 2021
Alloy Therapeutics and Pyxis Oncology Form Kyma Therapeutics to Develop Novel Immune-Modulating Antibodies for Cancer and Autoimmune Diseases
Read More
News | May 18, 2021
Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform
Read More
Press Release | March 31, 2021
Entrada Therapeutics Announces Closing of $116 Million Series B Financing
Read More
Press Release | March 30, 2021
Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics
Read More
Press Release | March 18, 2021
Pyxis Oncology Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Multiple Antibody-Drug Conjugates
Read More
News | March 18, 2021
CAR-M era begins as Carisma doses first patient
Read More
News | January 8, 2021
DiCE gets its ‘library’ card ready as it speeds development of DNA database-derived molecules with more investor cash
Read More
News | January 7, 2021
CARISMA Therapeutics Completes Series B Funding to Advance Development of Novel CAR-Macrophage Immunotherapies
Read More
